In MM cells, RNF6 as a ubiquitin ligase binds to and mediates K63-linked polyubiquitination toward the glucocorticoid receptor and promotes its oncogenic transcriptional activity, therefore contributing to MM cell survival and drug resistance (1). This evidence concerns the gene RNF6 and Miyoshi myopathy.